How to Deal With Chronic Patellar Instability: What Does the Literature Tell Us?

如何应对慢性髌骨不稳:文献告诉我们什么?

阅读:1

Abstract

CONTEXT: Patellar instability is a common clinical problem, affecting between 7 and 49 people per 100,000. However, not all patellar instabilities are equal, the etiology of the disorder is multifactorial, and a clear understanding of the cause of instability is crucial for appropriate surgical treatment. The goal of this article is to identify how to best treat patellar instability to provide good outcomes and hopefully prevent future osteoarthritis. EVIDENCE ACQUISITION: A PubMed search from 1983 through May 2015. STUDY DESIGN: Clinical review. LEVEL OF EVIDENCE: Level 4. RESULTS: Several subpopulations of patients with chronic patellar instability exist: (1) lateral patellar instability during the early arc of knee flexion (0°-30°), (2) lateral patellar instability persisting beyond 30° of knee flexion, (3) lateral patellar instability in greater knee flexion, and (4) medial patellar instability. In patients with lateral instability during the early arc of knee flexion, the medial patellofemoral deficiency is the essential lesion. Persistent instability beyond 30° of knee flexion suggests an unusually high patella, severe trochlear dysplasia, pathologic increment of the tibial tuberosity-trochlear groove distance, or a combination of these factors. In patients with lateral instability in greater knee flexion, increasing and unbalanced tension in the extensors pulls the patella out of the groove as the knee is flexed. Finally, medial patellar instability is an objective iatrogenic condition that appears after realignment surgery in the vast majority of cases. CONCLUSION: The etiology of chronic patellar instability is multifactorial, and its treatment must therefore be personalized. STRENGTH OF RECOMMENDATION TAXONOMY SORT: B.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。